Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Benjamin Georgiades"'
Autor:
Todd Riccobene, John Lock, Rosie D Lyles, Benjamin Georgiades, Michael Nowak, Pedro L Gonzalez, Jenny Park, Urania Rappo
Publikováno v:
Open Forum Infectious Diseases.
Background We assessed the efficacy and safety of dalbavancin, a long-acting lipoglycopeptide with activity against gram-positive pathogens, for treatment of acute bacterial skin and skin structure infections (ABSSSI) in patients with high body mass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb160b6ce4e50cc2def6c9f98d32f7cb
https://doi.org/10.1093/ofid/ofad256
https://doi.org/10.1093/ofid/ofad256
Publikováno v:
Open Forum Infectious Diseases. 9
Background PROVE is an ongoing international, retrospective study assessing cefiderocol (CFDC) for Gram-negative (GN) infections. Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are difficult-to-treat with limited treatment options. CF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205b392964bca51da21f8cc7d208183e
https://doi.org/10.1093/ofid/ofac492.718
https://doi.org/10.1093/ofid/ofac492.718
Autor:
Sean Nguyen, Benjamin Georgiades
Publikováno v:
Frontiers in Anti-infective Agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8a0a015e0f170d79776057ea200e618
https://doi.org/10.2174/9789811461835120030016
https://doi.org/10.2174/9789811461835120030016
Autor:
Joshua A Hayden, Vilma Zigmantaite, Chase A. Mazur, Ramune Grigaleviciute, Michael J. Satlin, Ruta Petraitiene, Thein Aung, Ethan Naing, Thomas J. Walsh, Vidmantas Petraitis, Audrius Kučinskas, Bo Bo Win Maung, Rimantas Stakauskas, Povilas Kavaliauskas, Benjamin Georgiades, Farehin Khan
Publikováno v:
Antimicrob Agents Chemother
Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is an emerging global public health threat that causes life-threatening pneumonia and bacteremia. Ceftazidime-avibactam (CZA) represents a promising advance for the treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa3d585c38c183ad00f344139f86ac3
https://doi.org/10.1128/aac.02157-19
https://doi.org/10.1128/aac.02157-19
Autor:
Benjamin Georgiades, Jie Chen, Jennifer S McGregor, Matthew W. McCarthy, Pedro L Gonzalez, Urania Rappo
Publikováno v:
Open Forum Infectious Diseases
Background Dalbavancin is a lipoglycopeptide with activity against Gram-positive pathogens responsible for ABSSSI, including methicillin-resistant Staphylococcus aureus (MRSA), and is FDA-approved as a single- or two-dose regimen. The objective of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffdf9ee9da392e2a14b544e6e0051b11
http://europepmc.org/articles/PMC5631734
http://europepmc.org/articles/PMC5631734
Autor:
Chase A. Mazur, Joshua A Hayden, Benjamin Georgiades, Michael J. Satlin, Farehin Khan, Thomas J. Walsh, Bo Bo Win Maung, Ruta Petraitiene, Vidmantas Petraitis
Publikováno v:
Open Forum Infectious Diseases
Background CRE have been identified by the CDC as one of three urgent antibiotic resistance threats. The international emergence of these pathogens has largely been driven by the dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC-Kp)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89762c26cc6ba420cb6b06234af1d400
https://doi.org/10.1093/ofid/ofx163.660
https://doi.org/10.1093/ofid/ofx163.660